Liang Rong | Neuroscience | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Liang Rong
Tianjin University, China

Liang Rong
Affiliation Tianjin University
Country China
Scopus ID 57214784288
Documents 20
Citations 192
h-index 8
Subject Area Neuroscience
Event International Academic Achievements & Awards
ORCID 0000-0002-1656-5941

Liang Rong is a researcher affiliated with Tianjin University, China, whose work is indexed in Scopus under the subject area of Neuroscience. This article presents the profile in connection with the Best Researcher Award at International Academic Achievements & Awards [4].

Abstract

This article summarises the academic profile of Liang Rong, a neuroscience researcher at Tianjin University, using publicly available bibliometric records. The summary draws on the Scopus author record and the ORCID registry [1][2]. It reviews the researcher’s indexed output, citation record, and the relevance of these indicators to the Best Researcher Award, and it is written in neutral, descriptive language.

Keywords

Neuroscience, Best Researcher Award, Tianjin University, Scopus, ORCID, h-index, research impact, academic recognition.

Introduction

Neuroscience is an interdisciplinary field concerned with the structure and function of the nervous system. Tianjin University is a public research university in China [6]. Liang Rong’s work is attributed to this institution in Scopus. Bibliometric indicators such as publication counts, citation totals, and the h-index are widely used to describe research output, although they offer only a partial view of scholarly contribution.

Research Profile

The researcher is identified in Scopus by Author ID 57214784288 and in the ORCID registry by the identifier 0000-0002-1656-5941 [1][2]. Persistent identifiers of this kind help distinguish researchers with similar names and link their publications to a single record. The profile is classified under the subject area of Neuroscience.

Research Contributions

The researcher’s contributions are recorded as scholarly documents indexed in Scopus within the neuroscience domain [1]. Specific topics, methods, and co-authors are best verified in the full author record. In summary, the profile is characterised by:

  • A sustained publication record of 20 indexed documents.
  • Work attributed to Tianjin University, China.
  • A publicly verifiable ORCID record linking research outputs [2].

Publications

The Scopus record lists 20 documents authored by Liang Rong [1]. Each indexed article carries a Digital Object Identifier (DOI), a persistent link to the published work [5]. Readers can locate individual publications and their DOIs through the sources below:

  • Scopus author record, listing documents and citation data [1].
  • ORCID works list, where self-reported publications and DOIs appear [2].
  • Crossref search results for DOI-registered articles [3].

Research Impact

Scopus reports 192 citations across 20 documents, an average of roughly 9.6 citations per document [1]. An h-index of 8 means that at least eight documents have each received at least eight citations. These figures reflect database coverage at the time of retrieval and may change as new citations are indexed.

Award Suitability

The Best Researcher Award at International Academic Achievements & Awards recognises researchers for scholarly output and contribution to their fields [4]. Liang Rong’s indexed publication record, citation count, h-index, and verifiable identifiers are consistent with the kind of evidence typically considered for such recognition. Final selection remains subject to the award committee’s criteria and review.

Conclusion

Liang Rong is a neuroscience researcher at Tianjin University with 20 Scopus-indexed documents, 192 citations, and an h-index of 8 [1]. The record provides a transparent, verifiable basis for consideration in connection with the Best Researcher Award [4].

References

  1. Elsevier. (n.d.). Scopus author details: Liang Rong, Author ID 57214784288. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57214784288
  2. ORCID. (n.d.). Liang Rong (ORCID iD 0000-0002-1656-5941). ORCID.
    https://orcid.org/0000-0002-1656-5941
  3. RTMS. (n.d.). RTMS Mitigates Simulated Spaceflight-Induced Emotional Dysfunction Through VEGFR-2-Mediated Neuroprotection.
    https://onlinelibrary.wiley.com/doi/10.1002/brb3.71799
  4. Syn III participated in rTMS-modulated emotional rescue in the prefrontal cortex under simulated space composite environment.
    https://www.nature.com/articles/s41380-025-03393-3
  5. PPN, (n.d.). AComparative Effects of Low-Intensity Focused Ultrasound Targeting PPN and STN on Motor Disorders in 6-OHDA Lesioned Mice.
    https://dl.acm.org/doi/10.1145/3794209.3794309

Saurabh Kumar Jha | Neuroscience | Best Researcher Award

Published on by Academic Achievements

Dr. Saurabh Kumar Jha | Neuroscience | Best Researcher Award

Assistant Professor | University of Delhi | India

Short Biography

Dr. Saurabh Kumar Jha is an accomplished Assistant Professor in the Department of Zoology at Kalindi College, University of Delhi. He has an impressive academic background, having earned his M.Sc. in Biotechnology from VIT University, Vellore, and a Ph.D. in Biotechnology with a specialization in Neurobiology from Delhi Technological University. Dr. Jha’s research focuses on stem cell technology, molecular chaperones, and ubiquitin E3 ligase in neurodegenerative disorders, as well as the therapeutic actions of biomolecules on aged neurons and muscles.

Profile

ORCID

Education

🎓 Dr. Jha’s educational journey began with an M.Sc. in Biotechnology from VIT University, Vellore. He further advanced his academic pursuits by obtaining a Ph.D. in Biotechnology from Delhi Technological University (formerly Delhi College of Engineering), where his research was centered on neurobiology. His doctoral thesis was titled “Signalling Mechanism and Therapeutics Action of Biomolecules in Neurodegenerative Disorder.”

Experience

💼 Dr. Jha has significant experience in academia and research. He is currently an Assistant Professor at Kalindi College, University of Delhi. Before this, he served as an Assistant Professor in the Department of Biotechnology at Sharda University. In these roles, he has demonstrated expertise in teaching, research, and placement coordination, guiding numerous Ph.D., M.Tech, M.Sc., and B.Sc. students.

Research Interest

🔬 Dr. Jha’s research interests are diverse and impactful. His primary focus is on stem cell technology and regenerative medicine, exploring molecular chaperones and ubiquitin E3 ligase in neurodegenerative disorders. Additionally, he investigates the therapeutic potential of biomolecules in aged neurons and muscles, aiming to develop innovative treatments for neurodegenerative diseases.

Awards

🏆 Dr. Jha has been recognized for his contributions to science with several prestigious awards. He received the “Commendable Research Excellence Award DTU 2018” from Delhi Technological University and the “Best Stem Cell Researcher Award 2019” from the University of Turin, Italy. These accolades highlight his excellence and dedication to advancing scientific knowledge and research.

Publications

📚 Dr. Jha has an extensive publication record with 160 papers in high-impact international journals. Some of his notable publications include:

  1. Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, et al. (2022). Antioxidants in brain tumors: current therapeutic significance and future prospects. Molecular Cancer, 21(1), 1-32. [Cited by 42 articles]
  2. Huang Z, Dewanjee S, Chakraborty P, Jha NK, Dey A, Gangopadhyay M, et al. (2023). CAR T cells: Engineered immune cells to treat brain cancers and beyond. Molecular Cancer, 22(1), 1-27. [Cited by 42 articles]
  3. Ye F, Dewanjee S, Li Y, Jha NK, Chen ZS, Kumar A, et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 1-40. [Cited by 42 articles]
  4. Chakraborty P, Das SS, Dey A, Chakraborty A, Bhattacharyya C, Kandimalla R, et al. (2022). Quantum dots: The cutting-edge nanotheranostics in brain cancer management. Journal of Controlled Release, 350, 698-715. [Cited by 14 articles]
  5. Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, et al. (2023). Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Research Reviews, 101838. [Cited by 14 articles]